Arava - Leflunomide - Dosage - Side Effects - Interactions - Warnings
Drugs A-Z: Arava / Leflunomide
Leflunomide (Arava) is the first isoxazol derivative approved for the treatment of rheumatoid arthritis. The drug is classified as a DMARD (disease-modifying anti-rheumatic drug).
Hair loss - What can people do who suffer hair loss from drugs?
Hair loss is an unwanted side effect of some arthritis drugs, such as methotrexate and Arava.
09/15/2005 Arava History: FDA Approves Generic Arava (Leflunomide)
09/15/2005, FDA grants final approval for Teva's leflunomide tablets.
03/07/2003 Arava History: FDA Panel Scrutinizes Safety Of 4 RA Drugs
03/07/2003, The risk versus benefit of Arava, Enbrel, Remicade, and Humira was reconsidered.
03/15/2001 Arava History: Arava Linked To Liver Problems
03/15/2001, EMEA issues public statement regarding Arava and serious hepatic reactions.
09/16/1998 Arava History: Arava (Leflunomide) Approved By FDA
09/16/1998, Arava is FDA approved for the treatment of active rheumatoid arthritis in adults.
08/12/1998 Arava History: Arava Recommended For FDA Approval
08/12/1998, Arava was unanimously recommended for FDA approval.